Jiménez-Expósito MJ - Search Results

1

Effect of malabsorption on nutritional status and resting energy expenditure in HIV-infected patients.

Jiménez-Expósito MJ, García-Lorda P, Alonso-Villaverde C, de Vírgala CM, Solà R, Masana L, Arija V, Izquierdo V, Salas-Salvadó J. Jiménez-Expósito MJ, et al. AIDS. 1998 Oct 22;12(15):1965-72. doi: 10.1097/00002030-199815000-00007. AIDS. 1998. PMID: 9814864

2

High-density lipoprotein concentrations relate to the clinical course of HIV viral load in patients undergoing antiretroviral therapy.

Alonso-Villaverde C, Segues T, Coll-Crespo B, Pérez-Bernalte R, Rabassa A, Gomila M, Parra S, Gozález-Esteban MA, Jiménez-Expósito MJ, Masana L. Alonso-Villaverde C, et al. AIDS. 2003 May 23;17(8):1173-8. doi: 10.1097/00002030-200305230-00009. AIDS. 2003. PMID: 12819519

3

Visceral leishmaniasis in HIV-infected patients with non-detectable HIV-1 viral load after highly active antiretroviral therapy.

Jiménez-Expósito MJ, Alonso-Villaverde C, Sardà P, Masana L. Jiménez-Expósito MJ, et al. AIDS. 1999 Jan 14;13(1):152-3. AIDS. 1999. PMID: 10207569 No abstract available.

4

Cytokine-driven inflammatory response is associated with the hypermetabolism of AIDS patients with opportunistic infections.

García-Lorda P, Serrano P, Jiménez-Expósito MJ, Fraile J, Bulló M, Alonso C, Bonada A, Viciana P, Luna PP, Salas-Salvadó J. García-Lorda P, et al. JPEN J Parenter Enteral Nutr. 2000 Nov-Dec;24(6):317-22. doi: 10.1177/0148607100024006317. JPEN J Parenter Enteral Nutr. 2000. PMID: 11071589

5

Infective Endocarditis in Patients on Chronic Hemodialysis.

Pericàs JM, Llopis J, Jiménez-Exposito MJ, Kourany WM, Almirante B, Carosi G, Durante-Mangoni E, Fortes CQ, Giannitsioti E, Lerakis S, Montagna-Mella R, Ambrosioni J, Tan RS, Mestres CA, Wray D, Pachirat O, Moreno A, Chu VH, de Lazzari E, Fowler VG Jr, Miró JM; ICE Investigators. Pericàs JM, et al. Among authors: jimenez exposito mj. J Am Coll Cardiol. 2021 Apr 6;77(13):1629-1640. doi: 10.1016/j.jacc.2021.02.014. J Am Coll Cardiol. 2021. PMID: 33795037 Free article.

6

Real-world experience with daclatasvir plus sofosbuvir ± ribavirin for post-liver transplant HCV recurrence and severe liver disease.

Herzer K, Welzel TM, Spengler U, Hinrichsen H, Klinker H, Berg T, Ferenci P, Peck-Radosavljevic M, Inderson A, Zhao Y, Jimenez-Exposito MJ, Zeuzem S. Herzer K, et al. Among authors: jimenez exposito mj. Transpl Int. 2017 Mar;30(3):243-255. doi: 10.1111/tri.12910. Transpl Int. 2017. PMID: 28012215 Free article.

7

Daclatasvir plus sofosbuvir, with or without ribavirin, in real-world patients with HIV-HCV coinfection and advanced liver disease.

Rockstroh JK, Ingiliz P, Petersen J, Peck-Radosavljevic M, Welzel TM, Van der Valk M, Zhao Y, Jimenez-Exposito MJ, Zeuzem S. Rockstroh JK, et al. Among authors: jimenez exposito mj. Antivir Ther. 2017;22(3):225-236. doi: 10.3851/IMP3108. Epub 2016 Nov 15. Antivir Ther. 2017. PMID: 27845298

8

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort.

Welzel TM, Petersen J, Herzer K, Ferenci P, Gschwantler M, Wedemeyer H, Berg T, Spengler U, Weiland O, van der Valk M, Rockstroh J, Peck-Radosavljevic M, Zhao Y, Jimenez-Exposito MJ, Zeuzem S. Welzel TM, et al. Among authors: jimenez exposito mj. Gut. 2016 Nov;65(11):1861-1870. doi: 10.1136/gutjnl-2016-312444. Epub 2016 Sep 7. Gut. 2016. PMID: 27605539 Free PMC article.

9

Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN Study.

Teófilo E, Rocha-Pereira N, Kuhlmann B, Antela A, Knechten H, Santos J, Jiménez-Expósito MJ; REMAIN study group. Teófilo E, et al. Among authors: jimenez exposito mj. HIV Clin Trials. 2016 Feb;17(1):17-28. doi: 10.1080/15284336.2015.1112494. HIV Clin Trials. 2016. PMID: 26899539 Free PMC article. Clinical Trial.

10

Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+).

Leroy V, Angus P, Bronowicki JP, Dore GJ, Hezode C, Pianko S, Pol S, Stuart K, Tse E, McPhee F, Bhore R, Jimenez-Exposito MJ, Thompson AJ. Leroy V, et al. Among authors: jimenez exposito mj. Hepatology. 2016 May;63(5):1430-41. doi: 10.1002/hep.28473. Epub 2016 Mar 4. Hepatology. 2016. PMID: 26822022 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters